pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.

Ormanns, Steffen; Siveke, Jens T; Heinemann, Volker; Haas, Michael; Sipos, Bence; Schlitter, Anna Melissa; Esposito, Irene; Jung, Andreas; Laubender, Rüdiger P; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; Fischer von Weikersthal, Ludwig; Clemens, Michael R; Gauler, Thomas C; Märten, Angela; Geissler, Michael; Greten, Tim F; Kirchner, Thomas; Boeck, Stefan

Ormanns, Steffen; Siveke, Jens T; Heinemann, Volker; Haas, Michael; Sipos, Bence; Schlitter, Anna Melissa; Esposito, Irene; Jung, Andreas; Laubender, Rüdiger P; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; Fischer von Weikersthal, Ludwig; Clemens, Michael R; Gauler, Thomas C; Märten, Angela; Geissler, Michael; Greten, Tim F; Kirchner, Thomas; Boeck, Stefan.

Affiliation

Boeck S; Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, München, Germany. stefan.boeck@med.uni-muenchen.de.

BMC Cancer ; 14: 624, 2014 Aug 28.

Article in En | MEDLINE | ID: mdl-25164437

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Quinazolines / Biomarkers, Tumor / Tumor Suppressor Protein p53 / EIF-2 Kinase / Extracellular Signal-Regulated MAP Kinases / Proto-Oncogene Proteins c-akt Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2014 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google